Delivery Order SPE2DE24D0021-SPE2D625F6X01
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,658.76 on August 8, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price delivery order with economic price adjustment serves the Medical Supply Chain, a defense-oriented federal agency, with performance to be completed by October 6, 2025, at Fisher Scientific's Pittsburgh, Pennsylvania facility. The contract represents a child award under a larger vehicle and carries no...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,650.00 on April 24, 2025, for the procurement of SOFIA 2 FLU + SARS antigen fluorescent testing supplies. This fixed-price contract with economic price adjustment is being performed in Pittsburgh, Pennsylvania, and is funded by the Defense-affiliated Medical Supply Chain agency. As a child contract under a larger vehicle, this delivery order represents a discrete procurement from Fisher Scientific's existing blanket...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,300.00 on August 18, 2025, for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price contract with economic price adjustment carries an ultimate completion date of October 15, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract is funded through the Medical Supply Chain, a defense-oriented federal agency, and is structured as a child contract under a...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,211.68 for SOFIA 2 Flu + SARS Antigen Fluorescent reagents under a fixed-price contract with economic price adjustment provisions. The award, issued on August 1, 2025, is classified as a child contract with an ultimate completion date of September 29, 2025. The place of performance is Pittsburgh, Pennsylvania. This delivery order was issued without a set-aside designation, reflecting Fisher Scientific's competitive...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,105.84 for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price delivery order with economic price adjustment was issued on August 7, 2025, with an ultimate completion date of October 3, 2025. The award was made through open competition with no set-aside designation. The work will be performed in Pittsburgh, Pennsylvania, and is funded by the Defense Department's Medical Supply Chain...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,300 for SOFIA 2 Flu + SARS antigen fluorescent diagnostic supplies by the Medical Supply Chain, a defense-focused federal agency, with an award date of September 4, 2025 and ultimate completion by October 31, 2025. The contract employs fixed-price pricing with economic price adjustment and carries no set-aside designation, reflecting open competition procurement. Performance will take place at Fisher Scientific's...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract valued at $2,764.60 by the Defense Medical Supply Chain for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic testing supplies. The delivery order, issued on August 8, 2025, is structured as a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of October 6, 2025. The work will be performed in Pittsburgh, Pennsylvania. This award represents a child...
- Fisher Scientific Company L.L.C., a major federal supplier of laboratory and medical equipment, was awarded a delivery order valued at $5,500 on September 12, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent immunodiagnostic supplies. This fixed-price delivery order with economic price adjustment provision will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of November 10, 2025. The contract was awarded without a set-aside designation, indicating open competition. The...
- The U.S. Department of Defense Medical Supply Chain awarded a $1,100 delivery order to Fisher Scientific Company L.L.C. on September 11, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent immunoassay products. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of November 7, 2025, and will be performed at Fisher Scientific's Pittsburgh, Pennsylvania facility. The award utilized no set-aside designation and represents a competitive procurement to...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract on August 14, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies with a ceiling value of $4,400. The contract, which operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by October 10, 2025, and will be performed in Pittsburgh, Pennsylvania. This delivery order was issued without a set-aside designation, reflecting Fisher Scientific's...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F6X01Delivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,100.00 on March 18, 2025, for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic supplies. The contract is a child order under a larger federal contract vehicle and carries a fixed-price structure with economic price adjustment provisions. The place of performance is located in Pittsburgh, Pennsylvania, and the work is scheduled for completion by May 13, 2025. This delivery order supports the Medical Supply Chain, a defense-oriented federal agency responsible for medical procurement and supply management. As an established vendor on the General Services Administration's Multiple Award Schedule, Fisher Scientific brings extensive experience in supplying laboratory and medical equipment to federal agencies, including the Department of Veterans Affairs, National Institutes of Health, and the Department of Defense. No set-aside designation was applied to this award, indicating open competition. The contract reflects Fisher Scientific's ongoing role as a critical supplier of specialized testing and diagnostic solutions to support federal healthcare and defense initiatives, building on its established relationships with government agencies since its registration in SAM.gov in 2001.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/18/25 |